Chetan B. Sangani

Design, synthesis and molecular modeling of pyrazole–quinoline–pyridine hybrids as a new class of antimicrobial and anticancer agents

Chetan B. Sangani, Jigar A. Makawana, Xin Zhang et al. · European Journal of Medicinal Chemistry · 2014 · 125 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +14

Microwave assisted synthesis of novel 4h-chromene derivatives bearing phenoxypyrazole and their antimicrobial activity assess

Chetan B. Sangani, Nimesh Shah, Manish P. Patel et al. · Journal of the Serbian Chemical Society · 2012 · 70 citations · Full text

Natural Sciences, Chemistry, Microbiology +13

Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAFV600E inhibitors

Mengyue Zhao, Yong Yin, Xiao‐Wei Yu et al. · Bioorganic & Medicinal Chemistry · 2014 · 68 citations

Pharmacy, Medicinal Chemistry, Oncology +15

Schiff’s base derivatives bearing nitroimidazole and quinoline nuclei: New class of anticancer agents and potential EGFR tyrosine kinase inhibitors

Jigar A. Makawana, Chetan B. Sangani, Lin Lin et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 55 citations · Full text

Medicine, Medicinal Chemistry, Oncology +16

An Overview of Privileged Scaffold: Quinolines and Isoquinolines in Medicinal Chemistry as Anticancer Agents

Yanna Mao, Kunjal Soni, Chetan B. Sangani et al. · Current Topics in Medicinal Chemistry · 2020 · 45 citations

Pharmacy, Medicinal Chemistry, Oncology +13